Yantai Zhenghai Bio-Tech Co Ltd (300653.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100002NZ1

Price
14.19 CNY
Market cap
2.55 bn CNY
P/E (2025)
30.99
P/S (2025)
7.01
Dividend yield
1.97 %
Net margin
22.63 %
Return on equity (ROE)
9.26 %
Return on assets (ROA)
8.37 %

Yantai Zhenghai Bio-Tech Co Ltd financials

Fiscal year20242025
Revenue363.23 m CNY364.14 m CNY
Gross profit317.09 m CNY312.71 m CNY
Operating income152.51 m CNY75.60 m CNY
EBIT152.61 m CNY88.14 m CNY
Net income134.64 m CNY82.41 m CNY
Diluted EPS – continuing operations0.75 CNY0.46 CNY

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Yantai Zhenghai Bio-Tech Co Ltd

Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral restoration membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etching agent, dental pit and fissure sealant, active biological bone, light-curing composite resin, non-absorbable surgical sutures, and self-etching adhesives. Its products are used in various fields, such as dentistry, orthopedics, neurosurgery, and trauma surgery. Yantai Zhenghai Biotechnology Co., Ltd. was founded in 2003 and is headquartered in Yantai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.